SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356576-22-000046
Filing Date
2022-05-12
Accepted
2022-05-12 17:15:35
Documents
93
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q supn-20220331.htm   iXBRL 10-Q 1441364
2 EX-31.1 supn-20220331x10qxex311.htm EX-31.1 9755
3 EX-31.2 supn-20220331x10qxex312.htm EX-31.2 10427
4 EX-32.1 supn-20220331x10qxex321.htm EX-32.1 4997
5 EX-32.2 supn-20220331x10qxex322.htm EX-32.2 5018
  Complete submission text file 0001356576-22-000046.txt   8076842

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20220331.xsd EX-101.SCH 57123
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20220331_cal.xml EX-101.CAL 102052
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20220331_def.xml EX-101.DEF 310704
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20220331_lab.xml EX-101.LAB 707108
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20220331_pre.xml EX-101.PRE 493801
87 EXTRACTED XBRL INSTANCE DOCUMENT supn-20220331_htm.xml XML 1371678
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 22918971
SIC: 2834 Pharmaceutical Preparations